This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IntelliPharmaCeutics International Inc (IPCI)

: Health Care

Company Cash Flow
Nov 2014 Nov 2013 Nov 2012 Nov 2011
Cash Flow From Operating Activities
Net Income (Loss) -3.86M -11.50M -6.14M -4.88M
Operating Gains/Losses 0.00 0.00 -145.72K 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 319.18K -1.37M 57.70K -1.76K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 869.41K
(Decrease) Increase In Payables -356.72K 74.14K -475.39K 203.74K
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 -107.09K 98.19K
Other Non-Cash Items 1.90M 5.64M -1.29M -3.52M
Net Cash From Continuing Operations -1.71M -6.93M -7.65M -6.98M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -1.71M -6.93M -7.65M -6.98M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -768.97K -122.02K -1.04M -262.14K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -768.97K -122.02K -1.04M -262.14K
Issuance of Debt 0.00 1.50M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 7.47M 6.71M 5.19M 12.09M
Repayment of Long-Term Debt -792.76K -49.99K -44.36K -824.00K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -719.84K -836.10K -779.27K 0.00
Net Cash From Financing Activities 5.96M 7.33M 4.36M 11.27M
Effect of Exchange Rate Changes 0.00 -16.04K 6.52K 2.38K
Net Change in Cash & Cash Equivalents 3.47M 263.57K -4.32M 4.03M
IPCI News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

IPCI IntelliPharmaCeutics International Inc

Chart of IPCI

Analysts Ratings for IPCI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET IPCI ANALYST REPORT

IPCI Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs